Michael Birrer, PI, Director, Gynecologic Medical Oncology, MGH Lari Wenzel, Co-PI, Prof. of Medicine, University of California, Irvine

Slides:



Advertisements
Similar presentations
Advanced Ovarian Cancer in Practice An Expert Commentary With Justin Chura, MD, MBA A Clinical Context Report.
Advertisements

Commission on Cancer Mission
Cancer Research UK strategy and funding Simon Vincent.
Update on Ovarian Cancer
Gynecologic Oncology Group Gynecologic Oncology Group Uterine Corpus Trials: GCIG David Scott Miller, M.D., F.A.C.O.G., F.A.C.S. Director and Dallas Foundation.
Intraperitoneal therapy in ovarian cancer Edward L. Trimble, MD, MPH National Cancer Institute, USA.
MMC Cancer Institute Navigation Program Donna Green BSN, RN,BA,OCN
†Source: U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2011 Incidence and Mortality Web-based Report. Atlanta (GA): Department.
Lesson 6: Telemedicine. What is telemedicine? Telemedicine is the remote diagnosis and treatment of patients by means of telecommunications technology.
Oncology The study of cancer. What is cancer? Any malignant growth or tumor caused by abnormal and uncontrolled cell division May be a tumor but it doesn’t.
Implementation of the Navigator Role in Community – Based Oncology Program Our Journey Joan M. Daugherty, RN, MS Executive Director, Richard A. Henson.
Cross-border biomarker research of ovarian cancerCrossBiomark (HUSRB/1203/214/091) The project is co-financed by the European Union
Consent for Research Study A Study for Women with Advanced Cervical Cancer: Learning whether an MRI scan with an investigative contrast agent (called.
CLL Research Consortium FISH studies, Core C June, 2005 NCI Submission.
Clinical & Translational Science: Individualizing Cancer Immunotherapy Scott A. Waldman, MD, PhD, FCP Thomas Jefferson University.
Positron Emission Tomography (PET) Scans in Ovarian Cancer Effectiveness of PET Scans and Recommendations for CMS August 20, 2008 Ovarian Cancer National.
Introducing Apceden™.
ACRIN 6657/CALGB Consent for Research Study Contrast-Enhanced Breast MRI and MRS: A Correlative Science Studies to Characterize Tumor Response in.
CTOS: A Herman Suit Legacy Michael A. Simon, MD The University of Chicago.
Colorectal Cancer Center Jena Introduction In Germany, there are currently approximately newly diagnosed patients with colorectal carcinoma.
Driving the Transition to Individualized Cancer Treatment by Addressing Critical Questions 1 Do I need surgery? chemotherapy? radiation? INVASIVE BREAST.
ACRIN Abdominal Committee ACRIN Gynecologic Committee Fall Meeting 2010.
Human Research Protection Programs 1a: How to Navigate Human Subject Protection Regulations Sponsored by the American Society for Investigative Pathology.
Interdisciplinary Collaboration: Challenges and Successes Michael S. Neal Scientific Director, ONE Fertility, 3210 Harvester Rd. Burlington, Ontario
Health Provider Teams: How you can support cancer survivors after treatment Washington CARES about Cancer Partnership: Survivorship Taskforce June 2012.
ACRIN 6671/GOG 0233 Consent for Research Study A study for Women with Advanced Cervical Cancer: Learning whether a PET/CT scan using an imaging agent called.
ACRIN Abdominal Committee ACRIN Gynecologic Committee Fall Meeting 2010 Susanna I Lee, MD, PhD, Chair Massachusetts General Hospital.
The Need for Organ Site Specific Cancer Research John T Isaacs Chemical Therapeutic Program Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
Precision Medicine A New Initiative. The Concept of Precision Medicine (PM) The prevention and treatment strategies that take individual variability into.
1 Jack London, PhD Research Professor, Cancer Biology Thomas Jefferson University Informatics Shared Resource Director Sidney Kimmel Cancer Center at Jefferson.
2011 ACRIN Annual Meeting The ACRIN Accrual Project at University of Washington Constance Lehman, MD. PhD David Mankoff, MD. PhD Tiffany Wong, MS.
File #1 Table of Contents Introduction Presenter’s Notes Oncology Rehabilitation: Web-based Learning for Physical Therapists Who Provide Rehabilitation.
Translational Science in Cancer Health Disparities Research Peter Ujhazy, M.D., Ph.D. Program Director Translational Research Program Division of Cancer.
The Future of Cancer Care The Future of Cancer Care Stephen C. Schimpff Executive Vice President, UMMC Interim Director, University of Maryland Greenebaum.
The Colorectal Cancer Center Jena Gharbi A, Settmacher U. Department of General, Visceral and Vascular Surgery, Friedrich-Schiller-University Jena
Targeting HER2 and Focusing on Patients With Gastric Cancer Jose Maria Vieitez, MD, PhD Assistant Professor of Oncology Department of Medical Oncology.
The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Fifth Annual African-American Prostate Cancer Disparity Summit September 24, 2009 Christine.
Michael Birrer Ian McNeish New Developments in Biology and Targets of Epithelial Ovarian Cancer.
OMICS Group Contact us at: OMICS Group International through its Open Access Initiative is committed to make genuine and.
The Value of Tissue Banks to Drug and Dx Developers Barbara L. Handelin, Ph.D. Conflicts of Interest, Privacy/Confidentiality, and Tissue Repositories:
Gynecologic Oncology Group Gynecologic Oncology Group (GOG) Sharon Stockman, C-CRC The University of Iowa Hospitals Iowa City, IA Chair, GOG Data Management.
Phase II Trial of Neoadjuvant Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated High Grade Unresectable Malignant Peripheral Nerve Sheath.
Challenges of Cancer Diagnosis in Resource Limited Settings Optimizing Pathology Support Ann Marie Nelson, M.D. AIDS and Infectious Disease Pathology Joint.
Colorectal Cancer Survivorship in Greene County, Pennsylvania: Assessment and Provider Education Mary Ann Ealy, Marlene Shaw and Carolyn Wissenbach Background.
Intensity-Modulated Radiotherapy is Associated with Improved Global Quality of Life Among Long-Term Survivors of Head and Neck Cancer Allen M. Chen, M.D.,
Consortium for Interdisciplinary Studies on Science for Aging.
Dr Godfrey Grech University of Malta
Enrollment and Monitoring Procedures for NCI Supported Clinical Trials Barry Anderson, MD, PhD Cancer Therapy Evaluation Program National Cancer Institute.
Electronic Dissemination of Hematologic Cancer Survivorship Materials with Application to the Adolescent and Young Adult (AYA) Community OHSU Cancer.
Kathleen Giacomini, Mark J. Ratain, Michiaki Kubo, Naoyuki Kamatani, and Yusuke Nakamura NIH Pharmacogenomics Research Network III & RIKEN Center for Genomic.
Quality of Life (QOL) & Patient Reported Outcomes (PRO) Lori Minasian, MD Chief, Community Oncology and Prevention Trials Research Group, DCP, NCI, NIH,
 Define Survivorship  Demonstrate understanding of the history of cancer survivorship  State the requirements of the Commission on Cancer of the American.
Florida Cancer Plan Phil Roland, MD FACS FACOG Florida State Chair A Commission on Cancer.
The Cancer Registry of Norway Jan F Nygård Head of the IT-department.
Linking Electronic Health Records Across Institutions to Understand Why Women Seek Care at Multiple Sites for Breast Cancer Caroline A. Thompson, PhD,
Cancer Moonshot. Purpose "The National Cancer Moonshot will work to accelerate these research efforts and break down barriers to progress by enhancing.
What should patients with BRAF mutant melanoma receive as front line therapy? Antoni Ribas, M.D. Professor of Medicine Professor of Surgery Professor of.
Survivorship Essentials for Practice Administrators Christina Bach, MBE, MSW, LCSW, OSW-C Carolyn Vachani, MSN, RN, AOCN.
R2 김재민 / Prof. 정재헌 Journal conference 1.
The Bridge from Patient to Scientist Comparison: BioBank and Cancer Registry Data Source Distinct Patients Percent BioBank % Cancer Registry %
Abramson Cancer Center Director’s Leadership Council March 13, 2017
Uterine serous carcinoma is more aggressive than high-grade serous ovarian carcinoma: a retrospective study H. Nagano1, Y. Tachibana1, M. Kawakami1, M.
Accelerating Precision Medicine for Advanced Cancer Patients
From Bench to Clinical Applications: Money Talks
Oncology Tru Miller White 2.
A Comparison of Quality-of-Life Domains and Clinical Factors in Ovarian Cancer Patients: A Gynecologic Oncology Group Study  Vivian E. von Gruenigen,
Trial Funding and Engagement: The NIH Sponsored CTSA Program
Cancer is a Challenge Cancer is common in humans – a public health problem ~1 of every 3 women will develop cancer ~1 of every 2 men will develop cancer.
Trends in survival from metastatic lung cancer in California,
A Comparison of Quality-of-Life Domains and Clinical Factors in Ovarian Cancer Patients: A Gynecologic Oncology Group Study  Vivian E. von Gruenigen,
Presentation transcript:

Michael Birrer, PI, Director, Gynecologic Medical Oncology, MGH Lari Wenzel, Co-PI, Prof. of Medicine, University of California, Irvine Finding the Key to Long-Term Survival for All Women

23,000 women in the USA each year are diagnosed with Ovarian Cancer 80% have an advanced stage cancer (Stage III or IV) 16,000 women in USA die of Ovarian Cancer each year But 10% Do Survive Long Term ! Finding the Key to Long-Term Survival for All Women

Who Are We? Finding the Key to Long-Term Survival for All Women

What is different about long-term (10+ years) survivors? Is it something about the patient or the tumor or both? What are the long-term consequences of the diagnosis and treatment of ovarian cancer? Finding the Key to Long-Term Survival for All Women

Goals PROs QOL PROs QOL Finding the Key to Long-Term Survival for All Women

Identify Stage 3 or 4 Ovarian Cancer Long-Term Survivors Collect Tissues and Characterize 1.Molecular markers (genetic, biochemical, immunology) 2.Patient Quality of Life Identify a Link Between 1 and 2 Establish Clinical Tools and Targeted Therapies Finding the Key to Long-Term Survival for All Women

Consortium Structure GOG Clinical Trials 39 Institutions Scientific Committee Research Sites Scientific Advisory Board Chair: Phil DiSaia Advocate Advisory Board Chair: Mary Scroggins Coordinating Center: MGH PI: Michael J. Birrer Co-PI: Lari Wenzel, Ph.D. Genomic, Biologic, Psychosocial Data Collection Clinical Conclusions: Tools and Targets GOG Tissue Bank 39 Institutions PATIENTS

The Gynecology Oncology Group Tissue Repository Patients Database 50 Principal Centers and 187 Participating Hospitals Multi-Modality Group with Over 2100 Participants GOG Clinical Trials Brought ALL the Major Improvements in the Management of Ovarian Cancer Finding the Key to Long-Term Survival for All Women

Ensures the project remains patient- and goal- focused, scientifically sound, and clinically relevant

Identification of Long-Term Survivors (10+ years) with Advanced Stage Ovarian Cancer (Stage III and IV only) Paraffin-Embedded Tumor Specimen from ANY Biopsy or Surgery “Quality of Life”, Toxicity and Medical Treatment Reports Finding the Key to Long-Term Survival for All Women

Please Contact The Long-Term Survivors Group: Finding the Key to Long-Term Survival for All Women